A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study

被引：0
|
作者：
Pavel, M. E. [1 ]
Ferone, D. [2 ]
Halperin, D. [3 ]
Myrehaug, S. [4 ]
Herrmann, K. [5 ,6 ]
Kunz, P. L. [7 ]
Chasen, B. [8 ]
Castillon, J. Capdevila [9 ]
Tafuto, S. [10 ]
Oh, D-Y. [11 ]
Yoo, C. [12 ]
Falk, S. [13 ]
Halfdanarson, T. R. [14 ]
Folitar, I. [15 ]
Zhang, Y. [16 ]
de Herder, W. W. [17 ]
Singh, S. [4 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nuernberg, Uniklinikum Erlangen, Dept Med 1, Erlangen, Germany
[2] Univ Genoa, IRCCS Policlin San Martino & DiMI, Endocrinol, Genoa, Italy
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Div Canc Med, Houston, TX 77030 USA
[4] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[6] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[7] Yale Univ, Yale Sch Med, New Haven, CT USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, Houston, TX 77030 USA
[9] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[10] Ist Nazl Tumori IRCCS Fdn G Pascale, Oncol Clin & Sperimentale Sarcomi & Tumori Rari, Naples, Italy
[11] Seoul Natl Univ, Seoul Natl Univ Hosp, Canc Res Inst, Coll Med, Seoul, South Korea
[12] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[13] Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol, Avon, England
[14] Mayo Clin, Div Med Oncol, Rochester, MN USA
[15] Novartis Pharma AG, Clin Dev, Basel, Switzerland
[16] Novartis Pharmaceut, Biostat, E Hanover, NJ USA
[17] Erasmus MC, Internal Med, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1148MO
引用
收藏
页码：S753 / S753
页数：1
相关论文
共 50 条
  • [31] [177LU]LU-DOTA-TATE AS FIRST-LINE THERAPY FOR PATIENTS WITH GRADE 2 AND 3 ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOURS (GEP-NETS): THE NETTER-2 STUDY
    Myrehaug, Sten
    Singh, Simron
    Pavel, Marianne
    Kunz, Pamela
    de Herder, Wouter
    Herrmann, Ken
    D'Amelio, Anthony, Jr.
    Santoro, Paola
    Folitar, Ilya
    Ferone, Diego
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S40 - S41
  • [32] Analysis of Somatostatin Receptor Imaging Modalities and the Relationship Between Tumor Uptake and Treatment Response to [177Lu]Lu-DOTA-TATE in Patients from the Randomized Phase 3 NETTER-2 study
    Herrmann, Ken
    Ferone, Diego
    Halperin, Daniel M.
    Myrehaug, Sten
    Pavel, Marianne
    Kunz, Pamela
    Chasen, Beth
    Capdevila, Jaume
    Tafuto, Salvatore
    Oh, Do-Youn
    Yoo, Changhoon
    Falk, Stephen
    Halfdanarson, Thorvardur R.
    Folitar, Ilya
    Zhang, Yufen
    de Herder, Wouter
    Singh, Simron
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [33] Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Dmochowska, Beata
    Mroz, Adrianna
    Zmudzki, Wawrzyniec
    Kaminski, Grzegorz
    PHARMACEUTICALS, 2023, 16 (09)
  • [34] Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry
    Riveira-Martin, Mercedes
    Struelens, Lara
    Iglesias, Jose Munoz
    Schoonjans, Werner
    Tabuenca, Olga
    Nogueiras, Jose Manuel
    Gomez, Francisco Javier Salvador
    Medina, Antonio Lopez
    EJNMMI PHYSICS, 2023, 10 (01)
  • [35] Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry
    Mercedes Riveira-Martin
    Lara Struelens
    José Muñoz Iglesias
    Werner Schoonjans
    Olga Tabuenca
    José Manuel Nogueiras
    Francisco Javier Salvador Gómez
    Antonio López Medina
    EJNMMI Physics, 10
  • [36] A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology
    Vasic, Valentina
    Gustafsson, Johan
    Nowshahr, Elham Yousefzadeh
    Stenvall, Anna
    Beer, Ambros J.
    Glatting, Gerhard
    Gleisner, Katarina Sjogreen
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 119
  • [37] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [38] Assessment of Occupational Radiation Exposure During Administration of [177Lu]Lu-DOTA-TATE Using Active and Passive Dosimetry
    Riveira-Martin, M.
    Struelens, L.
    Iglesias, J. Munoz
    Schoonjans, W.
    Alonso, J. M. Nogueiras
    Tabuenca, O.
    Gomez, F. J. Salvador
    Medina, A. Lopez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S226 - S227
  • [39] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Noémie S. Minczeles
    Eelke M. Bos
    Reinoud C. de Leeuw
    Johan M. Kros
    Mark W. Konijnenberg
    Jacoline E. C. Bromberg
    Wouter W. de Herder
    Clemens M. F. Dirven
    Johannes Hofland
    Tessa Brabander
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1195 - 1204
  • [40] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Minczeles, Noemie S.
    Bos, Eelke M. M.
    de Leeuw, Reinoud C. C.
    Kros, Johan M. M.
    Konijnenberg, Mark W. W.
    Bromberg, Jacoline E. C.
    de Herder, Wouter W. W.
    Dirven, Clemens M. F.
    Hofland, Johannes
    Brabander, Tessa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1195 - 1204
12345